|
Volumn 45, Issue 9, 2000, Pages 720-726
|
Oral contraceptives and epithelial ovarian cancer: Does dose matter?
a a a a a |
Author keywords
Contraceptives, oral; Ovarian cancer; Ovarian neoplasms
|
Indexed keywords
ESTROGEN;
ETHINYLESTRADIOL;
MESTRANOL;
ADULT;
AGED;
ARTICLE;
CANCER PREVENTION;
CANCER RISK;
CONTROLLED STUDY;
EDUCATION;
FEMALE;
HIGH RISK POPULATION;
HUMAN;
MAJOR CLINICAL STUDY;
MARRIAGE;
ORAL CONTRACEPTION;
OVARY CARCINOMA;
PARITY;
PRIORITY JOURNAL;
RISK ASSESSMENT;
AMERICAS;
BIOLOGY;
CANCER;
CASE CONTROL STUDIES;
CONTRACEPTION;
CONTRACEPTIVE METHODS;
DEVELOPED COUNTRIES;
DISEASES;
ENDOCRINE SYSTEM;
ESTROGENS;
FAMILY PLANNING;
HORMONES;
NEOPLASMS;
NORTH AMERICA;
NORTHERN AMERICA;
ORAL CONTRACEPTIVES;
OVARIAN CANCER;
PHYSIOLOGY;
RESEARCH METHODOLOGY;
RESEARCH REPORT;
RISK FACTORS;
STUDIES;
UNITED STATES;
WASHINGTON;
ADULT;
AGED;
CASE-CONTROL STUDIES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ESTROGENS;
FEMALE;
HUMANS;
INCIDENCE;
MIDDLE AGED;
ODDS RATIO;
OVARIAN NEOPLASMS;
RISK FACTORS;
|
EID: 0033804568
PISSN: 00247758
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (18)
|
References (18)
|